Biotechnology
VIR
10.42
price up icon3.07%   0.31
pre-market  Pre-market:  10.05   -0.37   -3.55%

Vir Biotechnology Inc (VIR)
full-star
loading
Overview News Price History Option Chain Financials Why VIR Down? Discussions Forecast

Why is Vir Biotechnology Inc (VIR) Stock down?

We've noticed a 13.06% decline in Vir Biotechnology Inc (VIR) stock during the 2025-01-13 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
20 Jul, 2023:

Shares of Vir Biotechnology were down 44.90% on Thursday after the company announced phase 2 trial results for an influenza A therapy candidate. Vir announced that VIR-2482 failed to meet efficacy endpoints in a phase 2 trial for treating influenza A. The highest dose showed a non-statistically significant 16% reduction in illness. Disappointingly, VIR-2842 is the company's sole wholly owned candidate.

https://www.fool.com/investing/2023/07/20/why-shares-of-vir-biotechnology-are-plunging-thurs/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article

Similar to VIR

biotechnology GMAB
$21.80
price up icon 4.81%
biotechnology INCY
$73.47
price up icon 2.14%
biotechnology SMMT
$22.10
price up icon 16.13%
biotechnology UTHR
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
biotechnology BNTX
$117.25
price up icon 4.75%
Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters
Cap:     |  Volume (24h):